Total Payments
$919.50
2023 Payments
$19.60
Companies
18
Transactions
47
Medicare Patients
4,614
Medicare Billing
$3.1M
Payment Breakdown by Category
Food & Beverage$903.95 (98.3%)
Other$15.55 (1.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $903.95 | 46 | 98.3% |
| Entertainment | $15.55 | 1 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $149.91 | 3 | $0 (2019) |
| Genentech, Inc. | $140.02 | 6 | $0 (2020) |
| Allergan, Inc. | $135.83 | 9 | $0 (2021) |
| Genentech USA, Inc. | $110.16 | 7 | $0 (2021) |
| Alimera Sciences, Inc. | $78.52 | 4 | $0 (2021) |
| Regeneron Healthcare Solutions, Inc. | $52.13 | 2 | $0 (2019) |
| EyePoint Pharmaceuticals US, Inc. | $35.88 | 2 | $0 (2020) |
| Spark Therapeutics, Inc. | $35.23 | 2 | $0 (2021) |
| Ocular Therapeutix, Inc. | $34.57 | 2 | $0 (2020) |
| Akorn Inc. | $23.29 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.60 | 1 | Regeneron Pharmaceuticals, Inc. ($19.60) |
| 2021 | $88.48 | 6 | Allergan, Inc. ($24.56) |
| 2020 | $142.12 | 9 | Allergan, Inc. ($39.33) |
| 2019 | $348.93 | 14 | Novartis Pharmaceuticals Corporation ($149.91) |
| 2018 | $148.75 | 8 | Genentech, Inc. ($53.17) |
| 2017 | $171.62 | 9 | Genentech USA, Inc. ($48.10) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/22/2023 | Regeneron Pharmaceuticals, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: OPHTHALMOLOGY | ||||||
| 12/02/2021 | Genentech USA, Inc. | SUSVIMO (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Immunology and Ophthalmology | ||||||
| 06/09/2021 | Allergan, Inc. | XEN GLAUCOMA TREATMENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: GLAUCOMA | ||||||
| 06/01/2021 | RxSight Inc | LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) (Device) | Food and Beverage | In-kind items and services | $8.44 | General |
| Category: Ophthalmology | ||||||
| 05/21/2021 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: OCULAR | ||||||
| 03/28/2021 | Alimera Sciences, Inc. | ILUVIEN (Drug) | Food and Beverage | Cash or cash equivalent | $14.27 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/18/2021 | Heidelberg Engineering, Inc. | Spectralis (Device) | Food and Beverage | Cash or cash equivalent | $11.79 | General |
| Category: Ophthalmology Imaging Equipment | ||||||
| 11/16/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 10/07/2020 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: CORTICOSTEROID INTRACANALICULAR INSERT | ||||||
| 08/11/2020 | EyePoint Pharmaceuticals US, Inc. | DEXYCU (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Postoperative Inflammation | ||||||
| 07/16/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: RETINA | ||||||
| 06/18/2020 | Allergan, Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $12.57 | General |
| Category: RETINA | ||||||
| 05/12/2020 | Genentech USA, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Ophthalmology | ||||||
| 04/23/2020 | Allergan, Inc. | COMBIGAN (Drug) | Food and Beverage | In-kind items and services | $12.97 | General |
| Category: OPHTHALMOLOGY | ||||||
| 01/24/2020 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Ophthalmology | ||||||
| 01/07/2020 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Ophthalmology | ||||||
| 12/05/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: RETINA | ||||||
| 11/01/2019 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/29/2019 | OPTOS, INC. | P200DTx (Device), P200T, P200TE | Entertainment | Cash or cash equivalent | $15.55 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/17/2019 | Novartis Pharmaceuticals Corporation | BEOVU (Drug) | Food and Beverage | In-kind items and services | $10.99 | General |
| Category: OPHTHALMOLOGY | ||||||
| 10/02/2019 | Spark Therapeutics, Inc. | LUXTURNA (Biological) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: OCULAR | ||||||
| 08/23/2019 | Allergan Inc. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: RETINA | ||||||
| 07/24/2019 | Genentech, Inc. | Lucentis (Biological) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Ophthalmology | ||||||
| 07/10/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $118.70 | General |
| 06/29/2019 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $20.22 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 11 | 2,171 | 6,812 | $3.9M | $1.4M |
| 2020 | 16 | 2,443 | 7,841 | $4.5M | $1.7M |
Total Patients
4,614
Total Services
14,653
Medicare Billing
$3.1M
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2021 | 103 | 1,208 | $2.4M | $890,841 | 37.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2021 | 27 | 883 | $627,813 | $222,713 | 35.5% |
| 67028 | Injection of drug into eye | Office | 2021 | 222 | 990 | $344,524 | $103,844 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 311 | 628 | $140,410 | $59,469 | 42.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 190 | 574 | $87,515 | $39,804 | 45.5% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 288 | 961 | $81,272 | $30,261 | 37.2% |
| J7999 | Compounded drug, not otherwise classified | Office | 2021 | 92 | 377 | $59,924 | $28,550 | 47.6% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 280 | 292 | $76,035 | $25,418 | 33.4% |
| 92250 | Photography of the retina | Office | 2021 | 491 | 730 | $76,272 | $21,846 | 28.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 86 | 86 | $28,977 | $10,260 | 35.4% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2021 | 81 | 83 | $15,695 | $7,818 | 49.8% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2020 | 112 | 1,317 | $2.6M | $976,095 | 37.8% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2020 | 58 | 1,216 | $864,576 | $326,833 | 37.8% |
| 67028 | Injection of drug into eye | Office | 2020 | 239 | 1,092 | $344,659 | $100,855 | 29.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 384 | 900 | $200,484 | $72,343 | 36.1% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 360 | 1,148 | $97,086 | $36,165 | 37.3% |
| J0179 | Injection, brolucizumab-dbll, 1 mg | Office | 2020 | 11 | 132 | $41,379 | $30,370 | 73.4% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 310 | 325 | $84,568 | $30,033 | 35.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 150 | 429 | $65,302 | $24,415 | 37.4% |
| J7999 | Compounded drug, not otherwise classified | Office | 2020 | 83 | 305 | $47,570 | $23,051 | 48.5% |
| 92250 | Photography of the retina | Office | 2020 | 447 | 666 | $69,557 | $22,744 | 32.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 95 | 95 | $32,009 | $11,045 | 34.5% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2020 | 93 | 95 | $17,965 | $7,735 | 43.1% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2020 | 46 | 62 | $8,804 | $3,766 | 42.8% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 12 | 13 | $1,719 | $638.90 | 37.2% |
About Dr. William Benedict, M.D
Dr. William Benedict, M.D is a Ophthalmology healthcare provider based in Longmont, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063598548.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Benedict, M.D has received a total of $919.50 in payments from pharmaceutical and medical device companies, with $19.60 received in 2023. These payments were reported across 47 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($903.95).
As a Medicare-enrolled provider, Benedict has provided services to 4,614 Medicare beneficiaries, totaling 14,653 services with total Medicare billing of $3.1M. Data is available for 2 years (2020–2021), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Retina Specialist
- Location Longmont, CO
- Active Since 10/27/2006
- Last Updated 05/10/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1063598548
Products in Payments
- Lucentis (Biological) $237.00
- OZURDEX (Drug) $98.30
- Iluvien (Drug) $43.00
- EYLEA (Biological) $39.37
- LUXTURNA (Biological) $35.23
- DEXTENZA (Drug) $34.57
- EYLEA AFLIBERCEPT INJECTION (Biological) $32.36
- XEN GLAUCOMA TREATMENT SYSTEM (Device) $24.56
- Zioptan (Drug) $23.29
- YUTIQ (Drug) $23.07
- Iluvien (Biological) $21.25
- VISUDYNE (Drug) $20.00
- Daraprim Tablet 25mg (Drug) $19.27
- Omidria (Drug) $17.08
- P200DTx (Device) $15.55
- ILUVIEN (Drug) $14.27
- SUSVIMO (Drug) $13.18
- COMBIGAN (Drug) $12.97
- DEXYCU (Drug) $12.81
- ForeseeHome (Device) $12.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Longmont
Elisha Tilton, Md, MD
Ophthalmology — Payments: $11,212
Ophthalmology $11,212
Micah Rothstein, M.d, M.D
Ophthalmology — Payments: $6,319
Ophthalmology $6,319
Richard Stewart, Md, MD
Ophthalmology — Payments: $5,164
Ophthalmology $5,164
Anjali Sheth, M.d, M.D
Ophthalmology — Payments: $4,346
Ophthalmology $4,346
Joel Meyers, M.d, M.D
Ophthalmology — Payments: $2,673
Ophthalmology $2,673
Mansi Parikh, Md, MD
Ophthalmology — Payments: $2,355
Ophthalmology $2,355